Endothelial expression of nitric oxide synthases and nitrotyrosine in systemic sclerosis skin

Journal of Pathology

Volumn 189, Issue 2, 1999, Pages 273-278

  Cotton, Shirley A ^a   Herrick, Ariane L ^b   Jayson, Malcolm I V ^b   Freemont, Anthony J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b HOPE HOSPITAL   (United Kingdom)

Author keywords

Endothelial cells; Free radicals; Nitric oxide; Nitric oxide synthase; Nitrotyrosine; Systemic sclerosis

Indexed keywords

3 NITROTYROSINE; CYTOKINE; FREE RADICAL; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

ARTICLE; CELL DAMAGE; CELL DEATH; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM LESION; HUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SKIN BIOPSY; SKIN DISEASE; SKIN FIBROSIS; SYSTEMIC SCLEROSIS; VASCULAR DISEASE;

ENDOTHELIUM, VASCULAR; HUMANS; IMMUNOENZYME TECHNIQUES; MICROCIRCULATION; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE II; NITRIC OXIDE SYNTHASE TYPE III; SCLERODERMA, SYSTEMIC; SEVERITY OF ILLNESS INDEX; SKIN; TYROSINE;

EID: 0032861895     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199910)189:2<273::AID-PATH413>3.0.CO;2-4     Document Type: Article

References (43)

1. Freemont AJ, Hoyland J, Fielding P, Hodson N, Jayson MIV. Studies of the microvascular endothelium in uninvolved skin of patients with systemic sclerosis: direct evidence for a generalised microangiopathy. Br J Dermatol 1992; 126: 561-568.
2. Prescott RJ, Freemont AJ, Jones CJP, Hoyland J, Fielding P. Sequential dermal microvascular and perivascular changes in the development of scleroderma. J Pathol 1992; 166: 255-263.
3. Hill MB, Phipps JL, Cartwright RJ, Milford Ward A, Greaves M, Hughes P. Antibodies to membranes of endothelial cells and fibroblasts in scleroderma. Clin Exp Immunol 1996; 106:491-497.
4. Mariq HR, Leroy EC. Patterns of finger capillary abnormalities in connective tissue disease by 'wide-field' microscopy. Arthritis Rheum 1973; 16: 619-628.
5. Herrick AL, Illingworth K, Blann A, Hay CR, Hollis S, Jayson MIV. Von Willebrand factor, thrombomodulin, thromboxane, beta-thromboglobulin and markers of fibrinolysis in primary Raynaud's phenomenon and systemic sclerosis. Ann Rheum Dis 1996; 55: 122-127.
6. Herrick AL, Oogarah PK, Freemont AJ, Marcuson R, Heaney M, Jayson MIV. Vasculitis in patients with systemic sclerosis and severe digital ischaemia requiring amputation. Ann Rheum Dis 1994; 53: 323-326.
7. Postlethwaite AE. Role of T cells and cytokines in effecting fibrosis. Int Rev Immunol 1995; 12: 227-246.
8. Klareskog L, Gustafsson R, Scheynius A, Hallgren R. Increased platelet derived growth factor type B receptors in the skin of patients with systemic sclerosis. Arthritis Rheum 1990; 33: 1534-1541.
9. Pearson JD. The endothelium: its role in scleroderma. Ann Rheum Dis 1991; 50 (Suppl 4): 866-871.
10. Umans JC, Levi R. Nitric oxide in the regulation of blood and arterial pressure. Annu Rev Physiol 1995; 57: 771-790.
11. Gross SS, Won MS. Nitric oxide: pathophysiological mechanisms. Annu Rev Physiol 1991; 57: 737-769.
12. Agostoni A, Marasini B, Biondi ML, et al. L-arginine therapy in Raynaud's phenomenon. Int J Clin Lab Res 1991; 21: 202-203.
13. Sakurai H, Hohsaka H, Liu MF, et al. Nitric oxide production and inducible nitric oxide synthase expression in inflammatory arthritides. J Clin Invest 1995; 96: 2357-2363.
14. McInnes IB, Leung BP, Field M, et al. Production of nitric oxide in the synovial membrane of rheumatoid and osteoarthritis patients. J Exp Med 1996; 184: 1519-1524.
15. Butler AR, Flitney FW. Nitric oxide, nitrosonium ions, nitroxide ions, nitrosothiols and iron-nitrosyls in biology: a chemist's perspective. Trends Pharmacol Sci 1995; 16: 18-22.
16. Suematsu M, Wakabayaski Y, Ishimura Y. Gaseous monoxides: a new class of microvascular regulator in the liver. Cardiovasc Res 1996; 32: 679-686.
17. Ye YZ, Strong M, Huang ZQ, Beckman JS. Antibodies that recognise nitrotyrosine. Methods Enzymol 1996; 269: 201-209.
18. Gow AJ, Duran D, Malcolm S, Ischiropoulos H. Effects of peroxynitrite-induced protein modifications on tyrosine phosphorylation and degradation. FEBS Lett 1996; 35: 63-66.
19. van der Vliet A, Eisenrich JP, Kaur H, Cross CE, Halliwell B. Nitrotyrosine as a biomarker for reactive nitrogen species. Methods Enzymol 1996; 269: 175-184.
20. Hoyland JA, Newson L, Jayson MIV, Freemont AJ. The vascular basement membrane in SSc skin. Heterogeneity of type IV collagen. Br J Dermatol 1993; 129: 384-388.
21. Griffith OW, Steuhr DJ. Nitric oxide synthase and catalytic mechanism. Annu Rev Physiol 1995; 57: 707-736.
22. Shimizu Y, Sakai M, Umemura Y, Ueda H. Immunohistochemical localization of nitric oxide synthase in normal human skin: expression of endothelial-type and inducible-type nitric oxide synthase in keratinocytes. J Dermatol 1997; 24: 80-87.
23. Balligand JL, Ungureanu-Longrois D, Simmons WW, et al. Induction of NO synthase in rat cardiac microvascular endothelial cells by IL-1 beta and IFN-gamma. Am J Physiol 1995; 268: H1293-H1303.
24. Darley-Usmar V, Wiseman H, Halliwell B. Nitric oxide and oxygen free radicals: a question of balance. FEBS Lett 1995; 368: 131-135.
25. Szabo C, Thiemermann C, Wu CC, Perretti M, Vane JR. Attenuation of the induction of nitric oxide synthase by endogenous gluco-corticoids accounts for endotoxin tolerance in vivo. Proc Natl Acad Sci USA 1994; 91: 221-225.
26. Herrick AL, Rieley F, Schofield D, Hollis S, Braganza JM, Jayson MI. Micronutrient antioxidant status in patients with primary Raynaud's phenomenon and systemic sclerosis. J Rheumatol 1994; 21: 1477-1483.
27. Singer II, Kawaka DW, Scott S, et al. Expression of inducible nitric oxide synthase and nitrotyrosine in colonie epithelium in inflammatory bowel disease. Gastroenterology 1996; 111: 871-885.
28. Rowe A, Farrell AM, Bunker CB. Constitutive endothelial and inducible nitric oxide synthase in inflammatory dermatoses. Br J Dermatol 1997; 136: 18-23.
29. Belmont HM, Levartovsky D, Goel A, et al. Increased nitric oxide production accompanied by the upregulation of inducible nitric oxide synthase in vascular endothelium from patients with systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1810-1816.
30. Ungureanu-Longrois D, Balligrand JL, Okada I, et al. Contractile responsiveness of ventricular myocytes to isoproterenol is regulated by induction of nitric oxide synthase activity in cardiac microvascular endothelial cells in heterotypic primary culture. Circ Res 1995; 77: 486-493.
31. Zhang J, Patel JM, Li YD, Block ER. Proinflammatory cytokines down-regulate gene expression and activity of constitutive nitric oxide synthase in porcine pulmonary artery endothelial cells. Res Commun Mol Pathol Pharmacol 1997; 96: 71-87.
32. Kanno K, Hirata Y, Imai T, Iwashina M, Marumo F. Regulation of inducible nitric oxide synthase gene by interleukin-1 beta in rat vascular endothelial cells. Am J Physiol 1994; 267: H2318-H2324.
33. Kaku Y, Nanri H, Sakimura T, Ejima K, Kuroiwa A, Ikeda M. Differential induction of constitutive and inducible nitric oxide by distinct inflammatory stimuli in bovine aortic endothelial cells. Biochim Biophys Acta 1997; 1356: 43-52.
34. Lopez Farre A, Mosquera JR, Sanchez de Miguel L, et al. Endothelial cells inhibit NO generation by vascular smooth muscle cells. Role of transforming growth factor beta. Arterioscler Thromb Vasc Biol 1996; 16: 1263-1268.
35. Akiba Y, Nakamura M, Oda M, et al. Basic fibroblast growth factor increases constitutive nitric oxide synthase during healing of rat gastric ulcers. J Clin Gastroenterol 1997; 25 (Suppl 1): 122-S128.
36. Bonmann E, Juttler E, Krestel HE, Spranger M. Heparain inhibits induction of nitric oxide synthase by cytokines in rat brain microvascular endothelial cells. Neurosci Lett 1998; 253: 95-98.
37. Gribbe O, Lundeberg T, Samuelson UE, Wiklund NP. Nitric oxide synthase activity and endothelial ultrastructure in ischaemic skin flaps. Br J Plast Surg 1997; 50: 483-490.
38. Cotton SA, Herrick AL, Jayson MI, Freemont AJ. TGFβ - a role in systemic sclerosis? J Pathol 1998; 184: 4-6.
39. Lau CS, O'Dowd A, Belch JJF. White blood cell activation in Raynaud's phenomenon of systemic sclerosis and vibration white finger. Ann Rheum Dis 1992; 51: 249-252.
40. Murrell DF. A radical proposal for the pathogenesis of scleroderma. J Am Acad Dermatol 1993; 28: 78-85.
41. Blann AD, Illingworth K, Jayson MIV. Mechanisms of endothelial cell damage in systemic sclerosis and Raynaud's phenomenon. J Rheumatol 1993; 20: 1325-1330.
42. Bruckdorfer KR, Hillary JB, Bunce T, Vancheeswaran R, Black CM. Increased susceptibility to oxidation of low-density lipoproteins isolated from patients with systemic sclerosis. Arthritis Rheum 1995; 38: 1060-1067.
43. Stein CM, Tanner SB, Awad JA, Roberts LJ, Morrow JD. Evidence of free radical-mediated injury (isoprostane overproduction) in scleroderma. Arthritis Rheum 1996; 39: 1146-1150.